Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FARICIMAB-SVOA vs FELBAMATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FARICIMAB-SVOA vs FELBAMATE: Safety Overview

Metric FARICIMAB-SVOA FELBAMATE
Total FAERS Reports 1,908 473
Deaths Reported 175 28
Death Rate 9.2% 5.9%
Hospitalizations 169 145
Average Patient Age 73.5 yrs 26.7 yrs
% Female Patients 57.0% 50.3%
FDA Approval Date N/A Apr 20, 2017
Manufacturer N/A Zydus Lifesciences Limited
Route N/A ORAL
Marketing Status Prescription Prescription